Research Partnership, a leading global healthcare market research and insights company has been acquired by Ashfield. The company will become part of Ashfield’s solution-oriented advisory and consulting division, Ashfield Advisory.
UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce two acquisitions in its Ashfield Communications and Advisory business. Putnam Associates (“Putnam”), a US-based strategic management healthcare consultancy, is being acquired for a total consideration of up to $88.6 million, and Incisive Health, a UK-based healthcare policy and communications consultancy, is being acquired for a total consideration of up to £13.6 million ($17.7 million).
UDG Healthcare plc has announced the acquisition of Create NYC, a New York-based disruptive creative communications agency and SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business, for a combined consideration of up to $82.4 million. Both companies are dedicated to the healthcare market
Press Release: UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the acquisition of MicroMass Communications (“MicroMass”), a US-based healthcare communications agency specialising in behavioural change, for a total consideration of up to $75.8m. MicroMass designs solutions across all therapeutic areas that improve patient and health outcomes by changing patient and provider behaviour. These solutions are created bespoke to the needs of each of MicroMass’ pharmaceutical clients. As the role of patients in healthcare decision making expands, coupled with the ongoing shift to digital channels, demand from pharmaceutical companies for behavioural change and direct patient engagement capabilities is increasing.
Press Release: 17 July 2017: UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the acquisition of Cambridge BioMarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35m.
Cambridge BioMarketing is an industry leader in orphan and rare disease drug launches, a fast-growing area of drug development and commercialisation. The orphan drug and rare disease market is forecasted to grow by a CAGR of 11% between 2017 and 2022 to $209bn, with orphan drugs estimated to account for 21.4% of prescription sales by 20221. Cambridge BioMarketing also has a strong creative and digital function in a market where digital content is becoming increasingly important for pharmaceutical companies.
Press Release 12 July 2017: UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the acquisition of Vynamic LLC, a US-based healthcare industry management consulting firm, for a total consideration of up to $32m
Press Release: UDG Healthcare plc, a leading international provider of healthcare services, announces that it has acquired STEM Marketing Limited, the leading global provider of commercial, marketing and medical audits to pharmaceutical companies for a total consideration of up to £84m ($103m)
UDG Healthcare confirmed yesterday that it is selling its drug distribution units across Ireland and a unit in its commercial services business to US drug wholesaler and Fortune 500 firm McKesson for €407.5m
Profit growth in the nine months to June has been driven by the strong performance of the Ashfield Commercial and Medical Services division.
Medex-Media, a division of KnowledgePoint360 Group has worked with healthcare clients to deliver effective exhibition and live event environments since 1985, delivering around 70 projects annually at major international congresses
Medex-Media, a division of KnowledgePoint360 Group has worked with healthcare clients to deliver effective exhibition and live event environments since 1985, delivering around 70 projects annually at major international congresses
MFRHRC Holdings Limited is being acquired for £6.5 million net cash on completion with an additional £6.5 million of the consideration payable based on achievement of agreed profit targets over the next 3 years
Ashfield Healthcare Communications this week announced a partnership with Ohio-based Within3, a specialist in enabling healthcare collaboration
